Stock listing
OTC:SLVNF Solvonis Therapeutics PLC Stock
US listing (OTC) of Solvonis Therapeutics PLC · home listing LSE:SVNS
Follow Solvonis Therapeutics PLC into a list and get an email when it puts out news.
Share price · OTC:SLVNF
$0.0008 USD
Close on Oct 21, 2026
- Day range
- $0.0008 – $0.0012 USDOct 21, 2026
- Volume
- 11,200 sharesOct 21, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:SVNS · Home | 0.095p GBX (pence) | 0.000 (0.0%) | 86,009,929 | 0.098p | 0.100p | 0.091p | 0.095p | Close on Nov 2, 2026 |
| OTC:SLVNF | $0.0008 USD | — | 11,200 | $0.0008 | $0.0012 | $0.0008 | — | Close on Oct 21, 2026 |
| Frankfurt:J4I | €0.0010 EUR | 0.0000 (0.0%) | — | €0.0010 | €0.0010 | €0.0010 | €0.0010 | Close on Oct 30, 2026 |
- Ticker
- OTC:SLVNF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Directorate change
Latest deck · Oct 13, 2026
Investor Presentation (October 2026)
Investor deck · 38 slides
Latest news
Financings
Private placement of new Ordinary Shares
Aug 25, 2026 · US$1.77M
Announced: £1.3M · £0.0012 a share · Turner Pope Investments (TPI) Limited
Dealers: Turner Pope Investments (TPI) Limited (lead)
Use of proceeds: Adding international sites to SVN-001 Phase 3, advancing SVN-002 towards US IND and Phase 2b, progressing SVN-015 with NIDA, and working capital
Decks
Investor Presentation (October 2026)
Investor deck · 38 slides · Oct 13, 2026
Investor Presentation (October 2026)
Investor deck · 37 slides · Oct 13, 2026
Investor Presentation (September 2026)
Investor deck · 26 slides · September 2026
Solvonis Therapeutics PLC on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 118 in all · newest Oct 30, 2026 · oldest 2022
- Decks
- 3 decks · latest Oct 13, 2026
Where Solvonis Therapeutics PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:SVNS · Home listing | LSE | United Kingdom | GBX |
| OTC:SLVNF · This page | OTC | United States | USD |
| LS Exchange:A3DCC0 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3DCC0 | Lang & Schwarz | Germany | EUR |
| gettex:J4I | gettex | Germany | EUR |
| Frankfurt:J4I | Frankfurt | Germany | EUR |
| Munich:J4I | Munich | Germany | EUR |
| Stuttgart:J4I | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Solvonis Therapeutics PLC.